AI
| Followers | 842 |
| Posts | 122795 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Tuesday, April 01, 2008 6:14:22 PM
>if things play out how Vertex was implying, Boceprevir may be a commercial flop.<
Well, VRTX is not exactly an unbiased observer
Zebra’s Law does not really apply to Big Pharma, so I have to assume that SGP thinks Boceprevir has what it takes to compete. Telaprevir’s TID dosing and mediocre tolerability profile leave the door open, IMO.
Well, VRTX is not exactly an unbiased observer
Zebra’s Law does not really apply to Big Pharma, so I have to assume that SGP thinks Boceprevir has what it takes to compete. Telaprevir’s TID dosing and mediocre tolerability profile leave the door open, IMO.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
